NCT06629675

Brief Summary

Pulmonary Rehabilitation (PR) is an evidence-based intervention to effectively manage the physiological and psychological effects of Chronic Obstructive Pulmonary Disease (COPD). The aims of PR are to improve symptoms of COPD, increase exercise capacity, increase independency, improve overall behaviour related to health (like exercising more), and enhance quality of life. The cornerstone of PR programmes is aerobic exercise prescription. Typically, walking exercise is used, and the prescription is individualised for each patient based on their maximal walking exercise capacity. However, adherence to walking exercise is challenging for service users, particularly when unsupervised at home. The use of music during exercise shows promise as a tool to decrease the perception of fatigue and increase motivation, but the integration of music via smartphone applications to support walking exercise adherence during PR has not been explored. This project aims to assess if a new mobile application BeatClearWalker (BCW) intervention is practical, acceptable, and effectively used by people living with COPD. The app is designed to help people living with COPD attending PR adhere to their prescribed walking pace during exercise. The BCW app provides real-time, personalised music feedback through music degradation to optimise the dose of walking exercise.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

April 20, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 12, 2025

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2025

Completed
Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

5 months

First QC Date

September 26, 2024

Last Update Submit

April 11, 2025

Conditions

Keywords

Auditory feedbackChronic Obstructive Pulmonary DiseasesDigital Health TechnologyExerciseExercise adherencePulmonary rehabilitationMobile applications

Outcome Measures

Primary Outcomes (5)

  • The proportion of recruited participants who do not use the BCW app.

    Post PR 6-8 weeks.

  • The proportion of recruited participants who complete the follow-up assessment.

    Upon the completion of the PR programme at 6-8 weeks.

  • The proportion of patients who meet the eligibility criteria.

    The percentage of eligible from those who were screened against the eligibility criteria

    11 months

  • The proportion of individuals with COPD who express interest in participating in the study.

    11 months

  • The proportion of eligible participants who provide consent to enrol.

    After meeting the eligibility criteria at the screening stage.

    11 months

Secondary Outcomes (15)

  • Medical Research Council (MRC) Dyspnoea Scale

    Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).

  • Generic Health Status Questionnaire (EQ-5D-5L)

    Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).

  • Generalized Anxiety Disorder 2-item (GAD-2)

    Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).

  • Generalized Anxiety Disorder 7-item (GAD-7)

    Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).

  • Walking exercise time at an individually prescribed cadence over the total time spent in walking exercise (Percent).

    Data collected after each walking exercise session during the PR programme (6-8 weeks).

  • +10 more secondary outcomes

Study Arms (1)

Music Walking Application BeatClearWalker (BCW)

EXPERIMENTAL

As it is a single-arm feasibility study, all participants will be allocated to one arm, receiving routine personalised walking exercise while listening to music from the smartphone using the music walking application BeatClearWalker during their Pulmonary rehabilitation Programme.

Device: Music walking application BeatClearWalker (BCW)

Interventions

The music walking application (BCW) is a smartphone application that can monitor the walking pace and allow individuals to listen to music and give immediate feedback so they can correct their walking pace to match their target walking speed, as prescribed by the healthcare professional. The application provides real-time audio feedback in the form of music; the music sound quality will reduce whenever the walking speed drops below or exceeds the participant\'s target walking speed. Simply, the application will work to supervise service users while exercising walking. The investigators are trying to assess the feasibility of this application with service users during their Pulmonary Rehabilitation programme (at the hospital/ home) to find out how participants interact with listening to music while exercise walking and how well they're able to keep to their target speed.

Music Walking Application BeatClearWalker (BCW)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Willing and able to provide informed consent for participation in the study.
  • The patient is referred for PR at the UHL.
  • The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria)
  • Male or female, aged 18+ years.
  • Able to communicate in written and spoken English.

You may not qualify if:

  • Unable to provide valid informed consent.
  • Lack of motivation to participate in PR programme.
  • Any-contra-indications absolute or relative to exercise training.
  • Has had a cardiac event within last 6 weeks
  • Severe psychiatric disorders
  • Patients with a history of MRSA +ve screens (patients can be assessed and given an exercise programme but cannot attend the classes. Patients need to have 3 consecutive -ve MRSA swabs before they can attend).
  • Unable to understand written or spoken English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

NIHR Leicester Biomedical Research Centre - Respiratory

Leicester, Leicestershire, LE3 9QP, United Kingdom

NOT YET RECRUITING

University Hospitals of Leicester (UHL)

Leicester, Leicestershire, LE3 9QP, United Kingdom

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Mark Orme, PhD

    University of Leicester

    PRINCIPAL INVESTIGATOR
  • Linzy Houchen-Wolloff, PhD

    NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust

    STUDY DIRECTOR
  • Sally J Singh, PhD

    NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust

    STUDY CHAIR

Central Study Contacts

Omar Alhothaly, MSc

CONTACT

Mark Orme, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2024

First Posted

October 8, 2024

Study Start

April 20, 2025

Primary Completion

September 12, 2025

Study Completion

September 26, 2025

Last Updated

April 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations